Introduction
Systemic vasculitis is often difficult to diagnose. The recent discovery of a new class of autoantibodies, the anti-neutrophil cytoplasmic autoantibodies (ANCA), provides clinicians with a serological test strongly supportive of the diagnosis of the commonest forms of systemic necrotizing vasculitis. ANCA are IgG autoantibodies specific for different constituents of neutrophil azurophilic granules and monocyte lysosomes. These antibodies are the first serological markers for several forms ofsystemic vasculitis, particularly Wegener's granulomatosis and polyarteritis nodosa, as well as for the commoner types of necrotizing and crescentic glomerulonephritis.' In addition to their recognized use in the diagnosis and follow-up of these conditions, it appears that ANCA may be a pathogenic factor inducing vascular injury in patients with ANCA-associated disease. This suspicion arises from in vitro evidence that ANCA are capable of activating neutrophils causing the release of lytic proteases and toxic oxygen radicals. 2 The existence of autoantibodies against neutrophils has been known for almost 30 years. A granulocyte-specific antinuclear factor was reported in 1964.3 Eight years later, Wiik and Munthe4 described a standardized method for the detection of granulocyte-specific anti-nuclear antibodies (GS-ANA). These investigators performed an indirect immunofluorescence (IIF) procedure on ethanol-fixed neutrophils, which remains the standard technique for ANCA detection today. GS-ANA were found to be specific for neutrophil and monocyte nuclei, did not react with lymphocytes, and were mainly detected in patients with rheumatic diseases, especially rheumatoid arthritis and Felty's syndrome, as well as in some patients with ulcerative colitis. The first solid-phase assay described was a RIA using an acid extract of neutrophils. 16 This resulted in a sensitivity of 96% and a specificity of 80%. The low specificity was due to false-positive reactions among systemic lupus erythematosus (SLE) patients. This may be expected, since a whole cellular extract is used which also contains nuclear antigens. Likewise, the acid extract of whole cells has also been used to develop an ELISA with the same drawbacks, that is, a high background and a high proportion of false-positive reactions."7 However, the solid-phase assays were greatly improved when it was shown that the c-ANCA antigen localized in the primary granules,'8 and assays were developed using purified extracts of these granules with a response at least 20 times better as compared with the whole cell extract. '9'20 This also resulted in a high specificity (greater than 95%), a sensitivity of 80-90% and there were no significant problems with false-positive reactions from SLE patients. Although this method mainly detects PR3, high serum concentrations of MPO or other azurophilic antigens may unfortunately also give a positive result. Another approach was taken by Ludemann et al.2' who used an affinity column with immunoglobulin from a patient with Wegener's granulomatosis. An ELISA using this method seems to be highly specific for c-ANCA and avoids the problem with false-positivity from other autoimmune sera. However, the antigen is difficult to purify. At the First International ANCA Workshop, this assay was found to correlate very well with the assay using purified granules.22 Finally, monoclonal antibodies against the c-ANCA antigen have also been used to capture the antigen in a solid-phase assay.23 This has the advantage of selecting monoclonal antibodies to the antigen of choice. However, a major problem in this type of assay is that many sera containing rheumatoid factors will react with these monoclonal antibodies and give a falsepositive result.
Since it is now well known that the major c-ANCA antigen is PR3, this protein is being used in many laboratories for detecting antibodies in solid-phase assays."' Likewise, after the discovery that the chief p-ANCA antigen was MPO,8 this well-characterized protein is also being used in solid-phase assays for MPO-ANCA detection in many centres. These assays are highly specific and sensitive for c-ANCA and p-ANCA, respectively. A small percentage of patients with p-ANCA will have anti-elastase or anti-lactoferrin antibodies which may also now be detected by means of specific ELISAs using either purified elastase or lactoferrin as a substrate.
The IIF procedure correlates well with the solid-phase assays in that the number of positive samples is roughly the same, but the antibody titres show a low correlation with the solid-phase readings. A high IIF titre may thus be low in the ELISA and vice versa. The ELISAs are, as expected, more sensitive than IIF, but the IIF will detect a few sera having specificities other than for the antigens used for coating in the solid-phase assays. Normally, between 80% and 90% of samples which are positive by IIF will be positive in ELISA, and about 90% ofsamples that are positive in ELISA will be positive in 11F. 24 The strategy used in many laboratories today is to screen for ANCA by IIF. Due to problems with interpretation of the IIF pattern, an ELISA is now often also needed to confirm the specificity. This is especially true when a p-ANCA pattern is seen. The p-ANCA pattern can mask a c-ANCA pattern or could actually be a true GS-ANA pattern or perhaps a regular ANA pattern seen in patients not suffering from systemic vasculitis. At all, one may then check for lymphocytes, which are negative with p-ANCA, and again perform the IIF with formaldehyde fixation. The pattern for MPO-ANCA with formaldehyde fixation will change from p-ANCA to granular cytoplasmic. If the pattern now remains nuclear, this probably represents the presence of ANA or a true GS-ANA."24 The strategy used in our centre is first to screen for ANCA by standard IIF. When c-ANCA are seen, we then perform an ELISA using purified PR3. When a p-ANCA pattern is seen, an ELISA with purified MPO is then performed. When the results are doubtful by IIF, we perform an ELISA using purified extract of primary granules as substrate ( Figure 1 (Figure 2 ). This type of immunostaining appears to be specific for MPO-ANCA and, when carefully examined, differs from other p-ANCA patterns that correspond to antibodies recognizing antigens other than MPO (Figure 3) .
There seems to be a functional analogy between the two major ANCA antigens, PR3 and MPO. Thus, both are co-localized in the azurophilic granules ofgranulocytes, and both are translocated to the cell surface during neutrophil activation." This has been recently established in human. 45 The two major ANCA antigens are able to interact directly with ANCA after neutrophil preactivation. Because of their cationic charge, both PR3 and MPO interact with cell membranes and glomerular basement membrane.46'47 The enzymatic activity of PR3 and MPO may be involved in the vascular lesions after ANCA amplified release. Indeed, PR3 has a capacity to degrade elastin and to induce emphysema in the hamster, exceeding that of elastase of cathepsin G. 30 Moreover, the MPOhydrogen peroxide-halide system is also directly involved in tissue injury through the generation of hypochlorous acid and chloramine radicals.47'48 MPO may also play an indirect role, since hypochlorous acid induces proenzyme activation of collagenase and gelatinase. 49 Minor ANCA antigens In addition to the two major ANCA antigens, a number of neutrophil cytoplasmic antigens recognized by ANCA have been also identified (Table I) . However, the small proportion of patients in whom Other ANCA antigens remain yet to be identified. In particular, the fine specificity of GS-ANA described by Wiik'2 occurring in rheumatoid arthritis and ulcerative colitis has not yet been recognized. During the Third International ANCA Workshop, Peter et al. 57 and Jorgensen et al. 58 established that GS-ANA were indeed heterogeneous with defined specificities to MPO, lactoferrin, or nuclear antigen(s) in 60% of the sera studied. The remaining 40% of sera contained antibodies to undefined cytoplasmic neutrophil antigen(s) and thus belong to the ANCA family.
Finally, it is the experience ofmany investigators that approximately 5% of the c-ANCA positive sera do not bind to P or a-granules, PR3, MPO, nor to the other rare ANCA antigens."
Conclusions
It seems to be clear that autoimmune mechanisms involving the neutrophil antigens are of growing importance. The role of the two major ANCA antigens, PR3 and MPO, in the vasculitic process, including Wegener's granulomatosis, is now well established. On-going studies will elucidate the role and specificity of ANCA in other conditions such as rheumatoid arthritis and ulcerative colitis. The variety of clinical conditions associated with ANCA is reflected by the large number of ANCA antigens described to date and, in future, no doubt the ANCA family will have other unexpected ramifications and implications.
